C4 Therapeutics Inc.
CCCC | NASDAQ
$3.37
+$0.07 (+2.12%)
Sep 22, 2026, 11:33 AM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 6.64M | 6.15M | 11.02M | 11.23M | 6.46M | 7.24M | 5.18M | 15.36M | 12.01M | 3.04M | 3.26M | 11.07M | 2.66M | 3.76M | 2.85M | 6.75M | 13.83M | 7.65M | 20.08M | 8.5M | 9.78M | 7.43M |
Cost of Revenue | n/a | 1.8M | n/a | n/a | n/a | n/a | 1.77M | 2.06M | 2.05M | n/a | 1.69M | 2M | n/a | 29.04M | 30.65M | 29.66M | 31.32M | 26.2M | 26.55M | 24.3M | 23.29M | 20.53M |
Gross Profit | 6.64M | 4.35M | 11.02M | 11.23M | 6.46M | 7.24M | 3.41M | 13.31M | 9.96M | 3.04M | 1.57M | 9.08M | 2.66M | -25.28M | -27.8M | -22.91M | -17.49M | -18.55M | -6.47M | -15.8M | -13.51M | -13.1M |
Operating Income | -26.42M | -27.79M | -23.15M | -34.41M | -28.5M | -29.16M | -37.71M | -28.24M | -21.44M | -32.22M | -37.43M | -27.81M | -37.57M | -36.23M | -38.29M | -32.49M | -27.38M | -31.37M | -15.26M | -24.25M | -22.12M | -41.04M |
Interest Income | 2.79M | 2.66M | 2.78M | 2.25M | 2.48M | 2.84M | 3.27M | 3.58M | 3.73M | 3.86M | 2.95M | 2.56M | 2.25M | 2.05M | 1.71M | 1.08M | 506K | 276K | 136K | 110K | 69K | 72K |
Pretax Income | -23.64M | -25.13M | -20.37M | -32.17M | -26.02M | -26.32M | -34.44M | -24.67M | -17.72M | -28.36M | -34.48M | -26.03M | -35.92M | -34.78M | -37.19M | -31.96M | -27.41M | -31.62M | -15.66M | -24.68M | -22.58M | -20.97M |
Net Income | -23.64M | -25.13M | -20.49M | -32.17M | -26.02M | -26.32M | -34.57M | -24.67M | -17.72M | -28.36M | -34.75M | -27.04M | -35.92M | -34.78M | -37.19M | -31.96M | -27.41M | -31.62M | -15.66M | -24.68M | -22.58M | -20.97M |
Selling & General & Admin | 8.59M | 7.53M | 9.18M | 8.92M | 8.77M | 9.33M | 10.37M | 11.77M | 9.7M | 10.29M | 8.61M | 10.53M | 10.31M | 10.95M | 10.5M | 9.58M | 9.9M | 12.82M | 8.78M | 8.45M | 8.61M | 7.41M |
Research & Development | 24.47M | 24.61M | 24.98M | 25.99M | 26.2M | 27.07M | 32.51M | 31.84M | 23.75M | 22.53M | 30.39M | 28.35M | 29.93M | 29.04M | 30.65M | 29.66M | 31.32M | 26.2M | 26.55M | 24.3M | 23.29M | 20.53M |
Other Expenses | n/a | n/a | n/a | 10.73M | n/a | n/a | -1.77M | -2.06M | -2.05M | 2.44M | n/a | -2M | n/a | -29.04M | -30.65M | -29.66M | -31.32M | -26.2M | -26.55M | -24.3M | -23.29M | n/a |
Operating Expenses | 33.06M | 32.14M | 34.16M | 45.64M | 34.96M | 36.4M | 41.12M | 41.55M | 31.4M | 35.26M | 39M | 36.89M | 40.23M | 10.95M | 10.5M | 9.58M | 9.9M | 12.82M | 8.78M | 8.45M | 8.61M | 27.94M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 167K | 600K | 606K | 601K | 554K | 534K | 527K | 539K | 539K | 533K | 534K |
Selling & Marketing Expenses | n/a | -1.8M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -1.69M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 33.06M | 33.94M | 34.16M | 45.64M | 34.96M | 36.4M | 42.89M | 43.61M | 33.45M | 35.26M | 40.69M | 38.88M | 40.23M | 39.99M | 41.15M | 39.24M | 41.22M | 39.02M | 35.33M | 32.75M | 31.9M | 48.46M |
Income Tax Expense | n/a | n/a | 121K | n/a | n/a | n/a | 131K | n/a | n/a | n/a | 277K | 1M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 130.7M | 126.07M | 116.78M | 72.56M | 71.01M | 70.83M | 70.61M | 69.63M | 68.81M | 68.43M | 51.22M | 49.21M | 49.06M | 49.03M | 48.97M | 48.92M | 48.82M | 48.65M | 48.49M | 48.49M | 43.86M | 43.08M |
Shares Outstanding (Diluted) | 130.7M | 126.07M | 116.78M | 72.56M | 71.01M | 70.83M | 70.61M | 69.63M | 68.81M | 68.43M | 51.22M | 49.21M | 49.06M | 49.03M | 48.97M | 48.92M | 48.82M | 48.73M | 48.49M | 48.49M | 43.86M | 43.08M |
EPS (Basic) | -0.18 | -0.20 | -0.18 | -0.44 | -0.37 | -0.37 | -0.49 | -0.35 | -0.26 | -0.41 | -0.68 | -0.55 | -0.73 | -0.69 | -0.74 | -0.64 | -0.56 | -0.66 | -0.32 | -0.51 | -0.51 | -0.49 |
EPS (Diluted) | -0.18 | -0.20 | -0.18 | -0.44 | -0.37 | -0.37 | -0.49 | -0.35 | -0.26 | -0.41 | -0.68 | -0.55 | -0.73 | -0.69 | -0.74 | -0.64 | -0.56 | -0.65 | -0.32 | -0.51 | -0.51 | -0.49 |
EBITDA | -23.34M | -23.33M | -19.94M | -31.71M | -25.41M | -25.87M | -32.68M | -22.61M | -15.67M | -29.33M | -32.79M | -23.87M | -34.86M | -33.63M | -36.06M | -30.99M | -26.44M | -30.79M | -14.8M | -23.81M | -21.66M | -20.06M |
EBIT | -23.64M | -25.13M | -20.37M | -32.17M | -26.02M | -26.32M | -34.44M | -24.67M | -17.72M | -29.78M | -34.48M | -25.87M | -35.32M | -34.17M | -36.58M | -31.4M | -26.88M | -31.09M | -15.12M | -24.14M | -22.05M | -20.51M |
Depreciation & Amortization | 292K | 1.8M | 428K | 460K | 615K | 456K | 1.77M | 2.06M | 2.05M | 448K | 1.69M | 2M | 458K | 545K | 521K | 415K | 435K | 305K | 323K | 330K | 388K | 451K |
Add to Watchlist
Select watchlists to add or remove CCCC